These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1332604)

  • 1. Combined treatment with 2'-nor-cGMP and ganciclovir against cytomegalovirus infection in a guinea pig model.
    Feng JS; Crouch JY; Tolman RL; Lucia HL; Hsiung GD
    Antiviral Res; 1992 Sep; 19(3):193-206. PubMed ID: 1332604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against cytomegalovirus infection in a guinea pig model.
    Fong CK; Cohen SD; McCormick S; Hsiung GD
    Antiviral Res; 1987 Jan; 7(1):11-23. PubMed ID: 3026243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) against guinea pig cytomegalovirus infection in cultured cells and in guinea pigs.
    Li SB; Yang ZH; Feng JS; Fong CK; Lucia HL; Hsiung GD
    Antiviral Res; 1990 May; 13(5):237-52. PubMed ID: 2168690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral effect of oxetanocin G against guinea pig cytomegalovirus infection in vitro and in vivo.
    Yamamoto N; Yamada Y; Daikoku T; Nishiyama Y; Tsutsui Y; Shimada N; Takahashi K
    J Antibiot (Tokyo); 1990 Dec; 43(12):1573-8. PubMed ID: 2177463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 2'-nor-cyclic GMP against guinea pig cytomegalovirus infection.
    Yang ZH; Lucia HL; Tolman RL; Colonno RJ; Hsiung GD
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1563-8. PubMed ID: 2554800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An animal model of neonatal cytomegalovirus infection.
    Bravo FJ; Bourne N; Schleiss MR; Bernstein DI
    Antiviral Res; 2003 Sep; 60(1):41-9. PubMed ID: 14516920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined antiviral effects of paired nucleosides against guinea pig cytomegalovirus replication in vitro.
    Yang ZH; Crouch JY; Feng JS; Chou TC; Hsiung GD
    Antiviral Res; 1990; 14(4-5):249-65. PubMed ID: 1965111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus infection in immunocompromised guinea pigs: a model for testing antiviral agents in vivo.
    Aquino-de Jesus MJ; Griffith BP
    Antiviral Res; 1989 Nov; 12(4):181-93. PubMed ID: 2559656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of two acycleonucleoside derivatives on ultrastructure and replication of guinea pig cytomegalovirus in cultured cells.
    Yang ZH; Klein S; Hsiung GD
    Intervirology; 1991; 32(5):297-307. PubMed ID: 1657821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of maternal treatment with cyclic HPMPC in the guinea pig model of congenital cytomegalovirus infection.
    Bravo FJ; Cardin RD; Bernstein DI
    J Infect Dis; 2006 Feb; 193(4):591-7. PubMed ID: 16425139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs.
    Schleiss MR; Bernstein DI; McVoy MA; Stroup G; Bravo F; Creasy B; McGregor A; Henninger K; Hallenberger S
    Antiviral Res; 2005 Jan; 65(1):35-43. PubMed ID: 15652969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for the treatment of murine cytomegalovirus infection in severe combined immunodeficiency mice.
    Neyts J; Balzarini J; Naesens L; De Clercq E
    J Med Virol; 1992 May; 37(1):67-71. PubMed ID: 1320099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of acyclovir and phosphonoformate on cytomegalovirus infection in guinea pigs.
    Lucia HL; Griffith BP; Hsiung GD
    Intervirology; 1984; 21(3):141-9. PubMed ID: 6327560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of murine cytomegalovirus disease does not prevent latent virus infection.
    Katzenstein DA; Crane RT; Jordan MC
    J Lab Clin Med; 1986 Aug; 108(2):155-60. PubMed ID: 3016127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of cytomegalovirus infection-enhanced experimental obliterative bronchiolitis by antiviral prophylaxis or immunosuppression in rat tracheal allografts.
    Tikkanen JM; Kallio EA; Bruggeman CA; Koskinen PK; Lemström KB
    Am J Respir Crit Care Med; 2001 Aug; 164(4):672-9. PubMed ID: 11520736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo activities of phosphate derivatives of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine against cytomegaloviruses.
    Duke AE; Smee DF; Chernow M; Boehme R; Matthews TR
    Antiviral Res; 1986 Aug; 6(5):299-308. PubMed ID: 3021055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized cytomegalovirus (CMV) infection and CMV-induced pneumonitis in the rat: combined effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine and specific antibody treatment.
    Stals FS; Wagenaar SS; Bruggeman CA
    Antiviral Res; 1994 Oct; 25(2):147-60. PubMed ID: 7847876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphonylmethoxyalkyl purine and pyrimidine derivatives for treatment of opportunistic cytomegalovirus and herpes simplex virus infections in murine AIDS.
    De Castro LM; Kern ER; De Clercq E; Ghaffar A; Mayer EP; Vogt PE; Gangemi JD
    Antiviral Res; 1991 Jul; 16(1):101-14. PubMed ID: 1663726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 9-(1-3-Dihydroxy-2-propoxymethyl)guanine prevents death but not immunity in murine cytomegalovirus-infected normal and immunosuppressed BALB/c mice.
    Wilson EJ; Medearis DN; Hansen LA; Rubin RH
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1017-20. PubMed ID: 2821884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of monoclonal antibody combined with ganciclovir or (S)-1-[3-hydroxy-(2-phosphonylmethoxy)-propyl]cytosine against murine cytomegalovirus infections in cell culture and in severe combined immunodeficient mice.
    Smee DF; Sugiyama ST; Sidwell RW; Barnett BB
    Chemotherapy; 1995; 41(2):141-8. PubMed ID: 7758358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.